Published in Arch Dis Child on May 01, 2005
Exacerbations in cystic fibrosis: 2 . prevention. Thorax (2007) 0.96
Validation and use of a parametric model for projecting cystic fibrosis survivorship beyond observed data: a birth cohort analysis. Thorax (2011) 0.96
Social and economic costs and health-related quality of life in non-institutionalised patients with cystic fibrosis in the United Kingdom. BMC Health Serv Res (2015) 0.83
Pulmonary exacerbations in cystic fibrosis and bronchiectasis. Thorax (2007) 0.78
Cystic fibrosis mortality trends in Spain among infants and young children: 1981-2004. Eur J Epidemiol (2008) 0.75
EXPERIMENTAL EPIDEMIC POLIOMYELITIS IN MONKEYS. J Exp Med (1910) 15.24
Fibrosing colonopathy in cystic fibrosis: results of a case-control study. Lancet (1995) 5.85
Infantile hypertrophic pyloric stenosis in Belfast, 1957-1969. Arch Dis Child (1975) 3.44
Cystic fibrosis in the United Kingdom, 1968-1988: incidence, population and survival. Paediatr Perinat Epidemiol (1993) 3.37
Concern about records of fibrosing colonopathy study. Lancet (2001) 3.27
THE PHYSIOLOGY OF THE IMMEDIATE REACTION OF ANAPHYLAXIS IN THE GUINEA-PIG. J Exp Med (1910) 2.78
Cystic fibrosis mortality and survival in the UK: 1947-2003. Eur Respir J (2006) 2.54
Relation between birth weight at term and systolic blood pressure in adolescence. BMJ (1994) 2.37
Can health visitors prevent fractures in elderly people? BMJ (1992) 2.25
Incidence, population, and survival of cystic fibrosis in the UK, 1968-95. UK Cystic Fibrosis Survey Management Committee. Arch Dis Child (1997) 2.12
Effect of storage and heat on antimicrobial proteins in human milk. Arch Dis Child (1978) 2.09
Production of duodenal ulcers and hypertrophic pyloric stenosis by administration of pentagastrin to pregnant and newborn dogs. Nature (1970) 2.00
Psychosomatic aspects of infantile pyloric stenosis. J Psychosom Res (1972) 1.92
Choosing who shall not be treated in the NHS. Soc Sci Med (1989) 1.87
Relationship between time-integrated C-reactive protein levels and radiologic progression in patients with rheumatoid arthritis. Arthritis Rheum (2000) 1.81
Infantile hypertrophic pyloric stenosis in South Glamorgan 1970-9. Effects of changes in feeding practice. Arch Dis Child (1983) 1.78
Inguinal hernia and a single strenuous event. Ann R Coll Surg Engl (1996) 1.68
Exploring self-efficacy as a predictor of disease management. Health Educ Behav (1999) 1.68
Congenital absence of islets of Langerhans. Arch Dis Child (1977) 1.65
Compliance with standardised assessment scales for elderly people among consultant geriatricians in Wessex. BMJ (1993) 1.63
Psychological determinants of infantile pyloric stenosis. Arch Dis Child (1978) 1.57
Confidential inquiry into families with two siblings with cystic fibrosis. Arch Dis Child (1997) 1.54
A PARALYTIC DISEASE OF GUINEA PIGS DUE TO THE TUBERCLE BACILLUS. J Exp Med (1929) 1.52
People's knowledge of health and disease. J Public Health Med (1990) 1.50
Hemorrhagic Hepatitis in Antitoxin Horses. J Med Res (1906) 1.47
Huntington's chorea in children. Report of four cases. Neurology (1967) 1.46
Nutrition and bronchopulmonary dysplasia. Arch Dis Child (1991) 1.42
Cell-free assays for gamma-secretase activity. FASEB J (2000) 1.41
Induction of pyloric hypertrophy by pentagastrin. An animal model for infantile hypertrophic pyloric stenosis. Gut (1976) 1.39
Screening for cystic fibrosis. Arch Dis Child (1982) 1.33
Comparative morphology of the tapetum lucidum (among selected species). Vet Ophthalmol (2004) 1.32
Birth weight at term and lung function in adolescence: no evidence for a programmed effect. Arch Dis Child (1995) 1.25
Defective beta-adrenergic secretory responses in submandibular acinar cells from cystic fibrosis patients. Lancet (1986) 1.23
Presenilin 1 regulates pharmacologically distinct gamma -secretase activities. Implications for the role of presenilin in gamma -secretase cleavage. J Biol Chem (2000) 1.22
Inequalities in access to knee joint replacements for people in need. Ann Rheum Dis (2004) 1.22
Life events and family history in children with recurrent abdominal pain. J Psychosom Res (1990) 1.21
ABO blood groups and infantile hypertrophic pyloric stenosis. Br Med J (1967) 1.20
Ion effects on the lac repressor--operator equilibrium. Biochemistry (1981) 1.20
Studies on the mechanism of phosphatidylinositol 3-kinase inhibition by wortmannin and related analogs. J Med Chem (1996) 1.18
Improving the primary management of emergency surgical admissions: a controlled trial. Ann R Coll Surg Engl (1995) 1.16
Supporting elderly dependent people at home. BMJ (1992) 1.15
Emerging therapies for the prevention or treatment of postmenopausal osteoporosis. J Med Chem (1999) 1.13
Molecular determinants of tissue selectivity in estrogen receptor modulators. Proc Natl Acad Sci U S A (1997) 1.10
Prostaglandin-induced diarrhoea. Arch Dis Child (1977) 1.08
Inequalities in accessing hip joint replacement for people in need. Eur J Public Health (2004) 1.08
Neonatal screening for cystic fibrosis in Wales and the West Midlands: 1. Evaluation of immunoreactive trypsin test. J Clin Pathol (1988) 1.08
Cystic fibrosis identified by neonatal screening: incidence, genotype, and early natural history. Arch Dis Child (1993) 1.06
Height and weight in cystic fibrosis: a cross sectional study. UK Cystic Fibrosis Survey Management Committee. Arch Dis Child (1997) 1.06
Cutis gyratum, acanthosis nigricans and other congenital anomalies. A new syndrome. Br J Dermatol (1969) 1.05
The relationship between symptoms of chronic disease and dependence. Int Disabil Stud (1990) 1.05
Pancreatic enzyme supplements in cystic fibrosis. Lancet (1992) 1.05
Orofacial granulomatosis in childhood. Br Dent J (1987) 1.04
Who is using cervical cancer screening services? Health Trends (1987) 1.04
Oral-facial-digital syndrome. Arch Dis Child (1967) 1.03
Recurrent abdominal pain in children. Br Med J (1976) 1.00
Screening for diabetic retinopathy by general practitioners: ophthalmoscopy or retinal photography as 35 mm colour transparencies? Diabet Med (1998) 0.99
HIV-1 dynamics in children. J Acquir Immune Defic Syndr Hum Retrovirol (1999) 0.99
Changes in functional health status of older women with heart disease: evaluation of a program based on self-regulation. J Gerontol B Psychol Sci Soc Sci (2000) 0.99
Respiratory distress syndrome in infants of Cardiff residents during 1965-75. Br Med J (1978) 0.98
Selective estrogen receptor modulators (SERMs). Curr Pharm Des (1998) 0.96
Determinants of pancreatic and pulmonary status of cystic fibrosis. Lancet (1991) 0.95
Randomised controlled trial of an aggressive nutritional regimen in sick very low birthweight infants. Arch Dis Child Fetal Neonatal Ed (1997) 0.95
Increased energy expenditure in cystic fibrosis is associated with specific mutations. Clin Sci (Lond) (1992) 0.94
Impact of self-management education on the functional health status of older adults with heart disease. Gerontologist (1992) 0.94
Self-regulation of health behavior: the "take PRIDE" program. Health Educ Q (1992) 0.94
Managing meningitis in children: audit of notifications, rifampicin chemoprophylaxis, and audiological referrals. Qual Health Care (1995) 0.94
Shwachman-Diamond syndrome: UK perspective. Arch Dis Child (2006) 0.92
Health visitor intervention to reduce days of unplanned hospital re-admission in patients recently discharged from geriatric wards: the results of a randomised controlled study. Arch Gerontol Geriatr (2004) 0.92
Low risk of thrombosis and serious embolic events despite low-intensity anticoagulation. Experience with 1,004 Medtronic Hall valves. Circulation (1988) 0.91
Letter: Essential fatty acid deficiency due to artificial diet in cystic fibrosis. Br Med J (1975) 0.90
Nature and standards of gastrointestinal and liver services in the United Kingdom. Gut (1993) 0.90
Effect of exercise on the nasal transmucosal potential difference in patients with cystic fibrosis and normal subjects. Thorax (1994) 0.89
Toddler diarrhoea and prostaglandins. Arch Dis Child (1981) 0.89
Factors influencing quality of life in older women with heart disease. Med Care (2001) 0.89
Differential effects of estrogen and raloxifene on messenger RNA and matrix metalloproteinase 2 activity in the rat uterus. Biol Reprod (2004) 0.89
High-strength pancreatic enzyme supplements and large-bowel stricture in cystic fibrosis. Lancet (1994) 0.88
Transformation of microbes, plants and animals by particle bombardment. Biotechnology (N Y) (1992) 0.87
Active immunity and T-cell populations in pigs intraperitoneally inoculated with baculovirus-expressed transmissible gastroenteritis virus structural proteins. Vet Immunol Immunopathol (1999) 0.87
A long-term five-year randomized controlled trial of hydroxychloroquine, sodium aurothiomalate, auranofin and penicillamine in the treatment of patients with rheumatoid arthritis. Br J Rheumatol (1998) 0.86
Aglossia-adactylia syndrome. Oral Surg Oral Med Oral Pathol (1970) 0.86
Survival estimates for adults with cystic fibrosis born in the United Kingdom between 1947 and 1967. The UK Cystic Fibrosis Survey Management Committee. Thorax (1999) 0.86
An evaluation of benthic macroinvertebrate biomass methodology : Part 1. Laboratory analytical methods. Environ Monit Assess (1983) 0.86
Long-chain 3-hydroxyacyl-coenzyme A dehydrogenase deficiency--diagnosis, plasma carnitine fractions and management in a further patient. Eur J Pediatr (1993) 0.85
Effects of an artificial diet on growth of patients with cystic fibrosis. Arch Dis Child (1978) 0.85
Gender differences in the associations of self esteem, stress and social support with functional health status among older adults with heart disease. J Women Aging (2001) 0.85
Two cases of trisomy D associated with adrenal tumours. J Med Genet (1972) 0.85
Gastrointestinal tract and nutrition in cystic fibrosis: pathophysiology. J R Soc Med (1986) 0.84
The children's Life Events Inventory. J Psychosom Res (1979) 0.84
Managing heart disease: a study of the experiences of older women. J Am Med Womens Assoc (1995) 0.84
Cystic fibrosis serum stimulates mucin secretion but not calcium efflux from rat submandibular acini. Clin Chim Acta (1983) 0.84
The nongenotropic synthetic ligand 4-estren-3alpha17beta-diol is a high-affinity genotropic androgen receptor agonist. Mol Pharmacol (2004) 0.83
Rat small intestinal morphology and tissue regulatory peptides: effects of high dietary fat. Br J Nutr (1991) 0.83
Accidents in childhood. Ulster Med J (1966) 0.83
Anticoagulation variability between centres: implications for comparative prosthetic valve assessment. Eur J Cardiothorac Surg (1988) 0.83
Proceedings: Maternal factor in infantile hypertrophic pyloric stenosis. Arch Dis Child (1974) 0.83
Adrenergic secretory responses of submandibular tissues from control subjects and cystic fibrosis patients. Clin Chim Acta (1985) 0.83
Precision of Larsen grading of radiographs in assessing progression of rheumatoid arthritis in individual patients. Ann Rheum Dis (1990) 0.82
Adjusting anticoagulation to prosthesis thrombogenicity and patient risk factors. Recommendations for the Medtronic Hall valve. Circulation (1991) 0.82
What factors influence functional ability in patients with rheumatoid arthritis. Do they alter over time? Rheumatology (Oxford) (2005) 0.82